Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor.

Kubitza, Dagmar

Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor. [electronic resource] - British journal of clinical pharmacology Nov 2010 - 703-12 p. digital

Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

1365-2125

10.1111/j.1365-2125.2010.03753.x doi


Administration, Oral
Adult
Aged
Area Under Curve
Cohort Studies
Creatinine--metabolism
Factor Xa Inhibitors
Female
Half-Life
Humans
Male
Metabolic Clearance Rate
Middle Aged
Morpholines--pharmacokinetics
Renal Insufficiency--metabolism
Rivaroxaban
Thiophenes--pharmacokinetics